Live from the NIH registry
Studies recruiting near Palmdale right now
Top 25 of 127 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: SWOG Cancer Research Network
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Olive View UCLA Medical Center — Sylmar, California (27.8 mi)
· Sponsor: Novartis Pharmaceuticals
Aveir AR Coverage With Evidence Development (CED) Study
Cardiac Pacemaker, Arrhythmia
N/A
Observational 586 participants sought
Abbott — Sylmar, California (27.8 mi)
· Sponsor: Abbott Medical Devices
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
Metastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 51 participants sought
Olive View-University of California Los Angeles Medical Center — Sylmar, California (27.8 mi)
· Sponsor: University of Washington
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Difficult to Control Hypertension
Phase 2
Interventional 120 participants sought
Amicis Research Center - Palmdale — Palmdale, California (1.2 mi)
· Sponsor: E-Star BioTech, LLC
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
Om Research, LLC — Lancaster, California (7.4 mi)
· Sponsor: Eli Lilly and Company
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Urinary Tract Infections
Phase 2
Interventional 318 participants sought
Research Site 131 — Lancaster, California (7.4 mi)
· Sponsor: Locus Biosciences
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (1.2 mi)
· Sponsor: BioStem Technologies
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Bowel; Stricture
Phase 3
Interventional 171 participants sought
Gastro Care Institute — Lancaster, California (7.4 mi)
· Sponsor: GIE Medical
Starting Technology in At Risk Type 1 Diabetes Study
Diabetes Mellitus, Type 1
N/A
Interventional 40 participants sought
Olive View-UCLA Medical Center — Sylmar, California (27.8 mi)
· Sponsor: University of California, Los Angeles
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Phase 3
Interventional 990 participants sought
Chemidox Clinical Trials Inc, Merz Investigational Site #0010488 — Lancaster, California (7.4 mi)
· Sponsor: Merz Therapeutics GmbH
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Metastatic Malignant Solid Neoplasm, Metastatic Pancreatic Adenocarcinoma
Phase 1
Interventional 58 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Tujunga, California (25.8 mi)
· Sponsor: GlaxoSmithKline
Aveir VR Coverage With Evidence Development Post-Approval Study
Cardiac Pacemaker, Arrythmia
N/A
Observational 8,744 participants sought
Abbott — Sylmar, California (27.8 mi)
· Sponsor: Abbott Medical Devices
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400001 — Lancaster, California (7.4 mi)
· Sponsor: Sanofi
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary Biliary Cholangitis
Phase 3
Interventional 318 participants sought
OM Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Gilead Sciences
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Alopecia Areata
Phase 2
Interventional 60 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (28.6 mi)
· Sponsor: Eli Lilly and Company
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Chagas Disease
Phase 2
Interventional 130 participants sought
Olive View UCLA Educ and Res Ins — Sylmar, California (27.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis, Atopic Dermatitis Eczema
Phase 2
Interventional 405 participants sought
Inmagene Site 1 — Lancaster, California (7.4 mi)
· Sponsor: Inmagene LLC
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
Treponema Pallidum, Treponema Pallidum Infection
N/A
Observational 1,000 participants sought
Chemidox Clinical Trials California — Lancaster, California (7.4 mi)
· Sponsor: American Laboratory Products Company
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: NRG Oncology
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
Lung Adenocarcinoma, Lung Large Cell Carcinoma
Phase 2
Interventional 42 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Amicis Research Center — Palmdale, California (1.2 mi)
· Sponsor: Rapport Therapeutics Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
City Of Hope - Antelope Valley /ID# 263138 — Lancaster, California (7.4 mi)
· Sponsor: AbbVie